Investor Presentaiton
US Business
Update on US FDA inspections
Manufacturing
Facility
Capability
Last inspection Status post last inspection
Bioequivalence
Taloja (India)
July 2021
Centre
Successfully closed inspection without any observations
Received 2 observations. Already sent a detail response to the
US FDA on the corrective and preventive actions being taken
St. Louis (US)
Formulations
June 2021
Baddi (India)
Formulations
February 2020
EIR# received in March 2020
Daman (India)
Formulations
August 2019
EIR# received in October 2019
California (US)
APIs
August 2018
EIR# received in October 2018
Ankleshwar (India)
APIs
December 2016
EIR# received in March 2017
Mandva (India)
APIs
September 2015
EIR# received in March 2016
O
e
ALKEMView entire presentation